These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30537404)

  • 1. Bioengineering nisin to overcome the nisin resistance protein.
    Field D; Blake T; Mathur H; O' Connor PM; Cotter PD; Paul Ross R; Hill C
    Mol Microbiol; 2019 Mar; 111(3):717-731. PubMed ID: 30537404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioengineering of the model lantibiotic nisin.
    Field D; Cotter PD; Ross RP; Hill C
    Bioengineered; 2015; 6(4):187-92. PubMed ID: 25970137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bioengineered Nisin Derivative To Control Streptococcus uberis Biofilms.
    Pérez-Ibarreche M; Field D; Ross RP; Hill C
    Appl Environ Microbiol; 2021 Jul; 87(16):e0039121. PubMed ID: 34105992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity.
    Molloy EM; Field D; O' Connor PM; Cotter PD; Hill C; Ross RP
    PLoS One; 2013; 8(3):e58530. PubMed ID: 23505531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.
    Li Q; Montalban-Lopez M; Kuipers OP
    Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogens.
    Field D; Begley M; O'Connor PM; Daly KM; Hugenholtz F; Cotter PD; Hill C; Ross RP
    PLoS One; 2012; 7(10):e46884. PubMed ID: 23056510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioengineered nisin derivatives with enhanced activity in complex matrices.
    Rouse S; Field D; Daly KM; O'Connor PM; Cotter PD; Hill C; Ross RP
    Microb Biotechnol; 2012 Jul; 5(4):501-8. PubMed ID: 22260415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The generation of nisin variants with enhanced activity against specific gram-positive pathogens.
    Field D; Connor PM; Cotter PD; Hill C; Ross RP
    Mol Microbiol; 2008 Jul; 69(1):218-30. PubMed ID: 18485077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel bioengineered derivative of nisin displays enhanced antimicrobial activity against clinical Streptococcus agalactiae isolates.
    Hayes K; Field D; Hill C; O'Halloran F; Cotter L
    J Glob Antimicrob Resist; 2019 Dec; 19():14-21. PubMed ID: 31054335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bypassing lantibiotic resistance by an effective nisin derivative.
    Zaschke-Kriesche J; Behrmann LV; Reiners J; Lagedroste M; Gröner Y; Kalscheuer R; Smits SHJ
    Bioorg Med Chem; 2019 Aug; 27(15):3454-3462. PubMed ID: 31253534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nisin M: a Bioengineered Nisin A Variant That Retains Full Induction Capacity but Has Significantly Reduced Antimicrobial Activity.
    O' Connor M; Field D; Grainger A; O' Connor PM; Draper L; Ross RP; Hill C
    Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32471915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of combinations of rationally selected bioengineered nisin derivatives for their ability to inhibit Listeria in broth and model food systems.
    Nyhan L; Field D; Hill C; Callanan M; Begley M
    Food Microbiol; 2021 Oct; 99():103835. PubMed ID: 34119119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nisin-relevant antimicrobial peptides: synthesis strategies and applications.
    Yuan L; Wu S; Tian K; Wang S; Wu H; Qiao J
    Food Funct; 2024 Sep; 15(19):9662-9677. PubMed ID: 39246095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z.
    Piper C; Hill C; Cotter PD; Ross RP
    Microb Biotechnol; 2011 May; 4(3):375-82. PubMed ID: 21375711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nisin as a model food preservative.
    Hansen JN
    Crit Rev Food Sci Nutr; 1994; 34(1):69-93. PubMed ID: 8142045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Solution Structure of the Lantibiotic Immunity Protein NisI and Its Interactions with Nisin.
    Hacker C; Christ NA; Duchardt-Ferner E; Korn S; Göbl C; Berninger L; Düsterhus S; Hellmich UA; Madl T; Kötter P; Entian KD; Wöhnert J
    J Biol Chem; 2015 Nov; 290(48):28869-86. PubMed ID: 26459561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive mutagenesis of the nisin hinge leads to the rational design of enhanced derivatives.
    Healy B; Field D; O'Connor PM; Hill C; Cotter PD; Ross RP
    PLoS One; 2013; 8(11):e79563. PubMed ID: 24244524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of extra-small nisin nanoparticles for enhanced antibacterial activity after autoclave treatment.
    Chang R; Lu H; Li M; Zhang S; Xiong L; Sun Q
    Food Chem; 2018 Apr; 245():756-760. PubMed ID: 29287437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of bifidobacteria to nisin.
    Rada V; Dlabal J
    Lett Appl Microbiol; 1998 Feb; 26(2):123-5. PubMed ID: 9569694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altering Specificity and Enhancing Stability of the Antimicrobial Peptides Nisin and Rombocin through Dehydrated Amino Acid Residue Engineering.
    Guo L; Stoffels K; Broos J; Kuipers OP
    Peptides; 2024 Apr; 174():171152. PubMed ID: 38220092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.